endocrinology top decile quiz
play

Endocrinology: top- decile quiz SBA Quiz Quiz Dr Shuaib Siddiqui, - PowerPoint PPT Presentation

Endocrinology: top- decile quiz SBA Quiz Quiz Dr Shuaib Siddiqui, MB BChir MRCP FY3 doctor Endocrinology series Content reviewed on the 05/05/2020. SBA Quiz Interactive SBA quiz competition Some answers are scored based on speed as


  1. Endocrinology: top- decile quiz SBA Quiz Quiz Dr Shuaib Siddiqui, MB BChir MRCP FY3 doctor Endocrinology series Content reviewed on the 05/05/2020.

  2. SBA Quiz • Interactive SBA quiz competition • Some answers are scored based on speed as well as accuracy • Topics covered: endocrinology • Total 14 questions • All answers to the SBAs will be uploaded after the webinar 2 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  3. 3 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  4. Acromegaly: pathophysiology 4 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  5. Acromegaly: investigations Beside • ECG: acromegaly can cause cardiomyopathy and heart failure Bloods • Insulin-like growth factor 1: first line investigation and raised in disease • Oral glucose tolerance test: a glucose load should cause suppression of GH normally. In acromegaly, there is failure of GH suppression Imaging • Pituitary MRI: visualisation of pituitary adenoma • CT chest, abdomen and pelvis: very rarely can be due to an ectopic source Special tests • Visual field testing 5 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  6. 6

  7. Prolactinoma: pathophysiology

  8. Prolactinoma: management Medical Dopamine agonist: cabergoline is preferred; dose increased for larger tumours • Surgical • Trans-sphenoidal surgery: if unresponsive or unable to tolerate medical therapy Pregnancy Discontinue dopamine agonist as soon as possible (most patients) • Selected patients with macroadenomas may continue medical therapy • 8 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  9. 9

  10. Hyperthyroidism: aetiology 10 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  11. Primary hyperthyroidism: aetiology Graves’ disease • Anti-TSH receptor antibodies • Most common cause of hyperthyroidism (75%) • Diffuse goitre and thyroid eye signs Toxic multinodular goitre • Iodine deficiency • Compensatory TSH secretion • Nodular goitre formation • Nodules become TSH-independent and thyroid hormones (1) 11 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  12. Secondary hyperthyroidism: aetiology Pituitary adenoma Ectopic tumour Hypothalamic tumour • • • TSH-secreting pituitary T4 secreting tumour (struma Excessive TRH secretion • adenoma ovarii) Rare cause of • hCG-secreting tumours (e.g. hyperthyroidism choriocarcinoma) Choriocarcinoma (2) 12 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  13. 13

  14. Thyroid disease: autoantibodies Thyroid autoantibodies Autoantibody Condition Prevalence Anti-TSH receptor Graves’ disease 90-100% Hashimoto’s thyroiditis 0-5% Anti-TPO Graves’ disease 70-80% Hashimoto’s thyroiditis 90-95% Anti-thyroglobulin Graves’ disease 20-40% Hashimoto’s thyroiditis 30-50% 14 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  15. 15

  16. Graves’ disease: management Antithyroid medication: • Carbimazole: usually first-line • Propylthiouracil : first-line pre-pregnancy or in the first trimester • Titration : titrate down to lowest effective dose • Block and replace : levothyroxine is added as needed Radioiodine: • First-line definitive management in Graves' and toxic multinodular goitre • Contraindicated in pregnancy, breastfeeding, and thyroid eye disease • Offer patient advice Surgery : total or hemithyroidectomy • Requires pre-operative optimisation • Be aware of the risks Other : consider propranolol for symptomatic relief 16 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  17. 17

  18. 18

  19. Hypothyroidism: aetiology TSH Free T4 ↑ ↓ Overt hypothyroidism ↑ Subclinical ↔ hypothyroidism 19 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  20. Hypothyroidism: management Overt hypothyroidism: • Levothyroxine (T4): offer levothyroxine with regular review of symptoms and TSH every 3 months • Pregnancy: increase dose • Ischaemic heart disease: reduce dose • Iron supplementation: reduces absorption so take 4 hours apart Subclinical hypothyroidism: • The below must be measured on 2 separate occasions 3 months apart: • TSH > 10 mU/L and normal T4: consider levothyroxine if TSH persistently > 10mU/L • TSH < 10 mU/L and normal T4: consider levothyroxine if symptomatic and < 65 years old • In all other cases observation is indicated 20 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  21. 21

  22. T1DM: management Urgent referral to diabetes specialist team Lifestyle • Diet high in fibre and low in fat, sugar, and salt • Educate regarding carbohydrate counting; allows insulin dose to be matched to intake Insulin therapy • Basal-bolus: first-line, long-acting regularly (basal) with rapid-acting insulin before meals (bolus) • Basal : Levemir (Detemir) given BD. Lantus (Glargine) is an alternative • Bolus : Novorapid (Aspart) • Mixed insulin regimen: mixed insulin comprises a short or rapid-acting and intermediate- acting insulin BD • Used when unable to tolerate basal-bolus regime • Continuous insulin infusion: disabling hypoglycaemia or persist hyperglycaemia (HbA1c >69mmol/mol) 22

  23. T1DM: insulin Type Onset Duration Examples Rapid 15 mins 2-5 hours Novorapid Humalog Short 30 mins 5-9 hours Actrapid Humulin S Intermediate 2 hours 12-24 hours Humulin I Insulatard Long 2-4 hours 16-42 hours Levemir Lantus 23 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  24. 24 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  25. DKA: diagnostic criteria Triad : hyperglycaemia, acidosis and ketonaemia Joint British Diabetes Societies (2013) Glucose > 11 mmol/L or known DM HCO3 < 15 mmol/L and/or venous pH < 7.30 Ketonaemia (>3 mmol/l) or 2+ ketonuria 25 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  26. DKA: management Treatment Further information IV fluid SBP < 90 mmHg 1 litre 0.9% NaCl over 15 mins • • Call for senior help as required SBP > 90 mmHg : typical regimen 1 litre 0.9% NaCl over 1 hour • 1 litre 0.9% NaCl with KCl over next 2 hours • 1 litre 0.9% NaCl with KCl over next 2 hours • 1 litre 0.9% NaCl with KCl over next 4 hours • 1 litre 0.9% NaCl with KCl over next 4 hours • 1 litre 0.9% NaCl with KCl over next 6 hours • Insulin Fixed-rate insulin infusion : • Commence at 0.1 U/kg/h • Add in 10% dextrose once glucose levels drop below 14.0 mmol/L • Do not stop long-acting insulin 26 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  27. DKA: management Serum potassium concentration (mmol/L) Potassium replacement > 5.5 None 3.5-5.5 40 mmol/L < 3.5 Consider HDU/ITU for replacement via central line • Potassium replacement: commence as per the table below • Total body potassium is low and correction of acidosis causes further reduction in potassium • Anticoagulation: patients are at increased risk of VTE • Glucose, pH, bicarbonate, ketone levels, and electrolytes should be closely monitored throughout, 1-2 hourly 27 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  28. 28 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  29. Please note, upon reviewing this question it has been retracted as the HbA1c in the question should have been > 58 mmol/mol 29 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  30. T2DM 30 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  31. T2DM: medication 31 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  32. T2DM: medication Drug class Side effects Biguanides GI upset AKI Sulfonylureas Hypoglycaemia Weight gain SGLT-2 inhibitor UTI Thiazolidinediones Weight gain Fluid retention DPP-4 inhibitor GI upset GLP-1 inhibitor GI upset Loss of appetite 32 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  33. 33

  34. Diabetes: monitoring Glucose HbA1c: measured every 3-6 months • Self-monitoring: only advised if on insulin • Retinopathy Immediate ophthalmology referral upon diagnosis and annually thereafter • Arrange urgent review thereafter if: • Acute reduction in acuity • Pre proliferative or proliferative retinopathy • Diabetic maculopathy • Diabetic foot Should be assessed at least annually; refer urgently to foot protection service if at risk (e.g. ulceration) • Diabetic nephropathy Annual measurement of eGFR and urinary albumin:creatinine ratio • 34 www.bitemedicine.com Instagram: @bitemedicine Facebook: /biteemedicine

  35. 35

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend